Monday, November 14, 2016
- 9:00AM-11:00AM
-
Abstract Number: 1165
The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine
Education - ARHP Poster- 9:00AM-11:00AM
-
Abstract Number: 1237
The Economic Burden of Dermatomyositis and Polymyositis in the US
Health Services Research - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1724
The Effect of Certolizumab Pegol on Skin Manifestations of Psoriatic Arthritis over 4 Years of Treatment
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster II: Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1872
The Effect of Cyclophosphamide on Pulmonary Function and Dependence on Disease Activity of Interstitial Lung Disease Associated with Systemic Sclerosis
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1851
The Effect of Narrow Band Ultraviolet A1 Light on Bleomycin-Induced Mouse Model of Scleroderma
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1155
The Effect of Nurse-Led Follow-up in Rheumatoid Arthritis. a Systematic Review and Meta-Analysis of Randomized Controlled Trails
Education - ARHP Poster- 9:00AM-11:00AM
-
Abstract Number: 1523
The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications- 9:00AM-11:00AM
-
Abstract Number: 1449
The Efficiency of the Regulation of Ca2+ Entry through Calcium Release-Activated Calcium Channel in the Treatment of Rheumatoid Arthritis
Rheumatoid Arthritis – Animal Models - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1119
The Enhanced Expression of mRNA for Calgranulins, S100A8, S100A9 and S100A12, in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster I- 9:00AM-11:00AM
-
Abstract Number: 1439
The EP4 Receptor Antagonist CR6086 Is More Effective Than Classical NSAID and DMARD Treatment in a Murine Model of Arthritis and in Human RA Synovial Explants
Rheumatoid Arthritis – Animal Models - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1168
The Epidemiology of Individuals Not Fully Meeting Classification Criteria for Systemic Lupus Erythematosus (SLE): The Georgia Lupus Registry
Epidemiology and Public Health - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1432
The EULAR Systemic Sclerosis Impact of Disease Score – a New Patient-Reported Outcome Measure for Patients with Systemic Sclerosis Under Development
Quality Measures and Quality of Care - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1140
The Future of Rheumatology: Pediatric and Adult Fellows-in-Training Results from the 2015 ACR/ARHP Workforce Study
Education - Poster- 9:00AM-11:00AM
-
Abstract Number: 1794
The High Disease Activity State Is an Adverse Prognostic Indicator in SLE and Defines a Clinically Distinct Population